FAP and infection: Another important consideration for developing vaccines against E. multilocularis established its infection in the liver is to find a more efficient adjuvant that is able to offset the undesired effect of proteins like antigen B and tetraspanin which is believed to cause a shift from protective Th1 response to non-protective Th2 response [13], [48], or fuse FAP with other protective Ags.